Tudor Investment Corp
EGRX

Tudor Investment Corp’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Tudor Investment Corp’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-28,875
Closed -$455K – 3001
2023
Q3 		$455K Buy
+28,875
New +$519K ﹤0.01% 1725
2023
Q1 		– Sell
-32,382
Closed -$947K – 3057
2022
Q4 		$947K Buy
32,382
+4,921
+18% +$156K 0.02% 1138
2022
Q3 		$726K Buy
27,461
+4,668
+20% +$171K 0.02% 1143
2022
Q2 		$1.01M Buy
+22,793
New +$1.05M 0.03% 878
2020
Q1 		– Sell
-7,425
Closed -$446K – 1386
2019
Q4 		$446K Sell
7,425
-13,353
-64% -$796K 0.02% 758
2019
Q3 		$1.18M Buy
20,778
+10,875
+110% +$612K 0.04% 448
2019
Q2 		$551K Sell
9,903
-1,967
-17% -$103K 0.02% 679
2019
Q1 		$599K Sell
11,870
-9,374
-44% -$417K 0.02% 638
2018
Q4 		$856K Buy
21,244
+8,667
+69% +$447K 0.02% 437
2018
Q3 		$872K Buy
12,577
+8,544
+212% +$648K 0.02% 508
2018
Q2 		$305K Buy
+4,033
New +$254K 0.01% 812
2016
Q3 		– Sell
-7,000
Closed -$272K – 1789
2016
Q2 		$272K Buy
7,000
+1,600
+30% +$66.6K 0.01% 1232
2016
Q1 		$219K Sell
5,400
-1,067
-16% -$67.7K 0.01% 1465
2015
Q4 		$573K Buy
+6,467
New +$511K 0.02% 774

Other funds holding EGRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Tudor Investment Corp's EGRX Position: Q4 2023 in Review

Tudor Investment Corp sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q4 2023, closing a stake of 28,875 shares — an estimated $455K sold.

Tudor Investment Corp first reported a position in EGRX in Q4 2015 and held it in 14 quarters. The position peaked at $1.18M in Q3 2019. 104 funds tracked by Wall St. Rank hold EGRX as of Q4 2023.

  • Tudor Investment Corp reported no remaining Eagle Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
  • Tudor Investment Corp sold 28,875 Eagle Pharmaceuticals, Inc. shares in Q4 2023, an estimated $455K.
  • Tudor Investment Corp first reported a position in Eagle Pharmaceuticals, Inc. in Q4 2015 and held it in 14 quarters.
  • Tudor Investment Corp's Eagle Pharmaceuticals, Inc. position peaked at $1.18M in Q3 2019.
  • 104 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q4 2023.

Based on Tudor Investment Corp's 13F filing for Q4 2023, filed 14 Feb 2024.